Jefferies Group’s Salix Pharmaceuticals SLXP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q2
– Sell
-1,489,300
Closed -$257M – 3685
2015
Q1
$257M Buy
1,489,300
+1,249,800
+522% +$183M 1.44% 10
2014
Q4
$27.5M Sell
239,500
-23,500
-9% -$2.85M 0.16% 112
2014
Q3
$41.1M Buy
+263,000
New +$38.1M 0.28% 60

Other funds holding SLXP

Jefferies Group's SLXP Position: Q2 2015 in Review

Jefferies Group sold out of Salix Pharmaceuticals (SLXP) in Q2 2015, closing a stake of 7,043 shares — an estimated $1.22M sold.

Jefferies Group first reported a position in SLXP in Q2 2013 and held it in 6 quarters. The position peaked at $4.9M in Q4 2014. 1 fund tracked by Wall St. Rank holds SLXP as of Q2 2015.

  • Jefferies Group reported no remaining Salix Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
  • Jefferies Group sold 7,043 Salix Pharmaceuticals shares in Q2 2015, an estimated $1.22M.
  • Jefferies Group first reported a position in Salix Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • Jefferies Group's Salix Pharmaceuticals position peaked at $4.9M in Q4 2014.
  • 1 fund tracked by Wall St. Rank held Salix Pharmaceuticals as of Q2 2015.

Based on Jefferies Group's 13F filing for Q2 2015, filed 18 Aug 2015.